IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 478
Titolo Data di pubblicazione Autore(i) File
New charges for n7 alkylated purines useful for conformational searching of nucleic acid adducts: application to azinomycin B - DNA interactions 1-gen-2001 Alcaro, S; Coleman, R. S.; Ortuso, F
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanedyil)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflam-matory activity 1-gen-2001 Ottanà, R; Monforte, F; DE LUCA, G; Maccari, R; Ortuso, F; Vigorita, M. G.; Alcaro, S
Probing the inverse agonist/antagonist interaction at CBR: drug design, synthesis, and biological evaluation of 6-aryl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds 1-gen-2001 Braile, C.; Cappelli, A.; Vomero, S.; Alcaro, S; Gallelli, A.; Biggio, G.; Lucacchini, A.; Giannaccini, G.; Betti, L.; Anzini, M.
Monte Carlo simulation of DNA - azinomycin B interaction: case study of CPU intensive calculations distributed on UNIX platforms 1-gen-2001 Alcaro, S; Ortuso, F.; Coleman, R. S.
Development of Selenium based molecular mechanics parameters: an application to antisense nucleotides 1-gen-2001 Tafi, A; Ortuso, F; Wozniak, L. A.; GÁCS-BAITZ, E; Botta, M; Alcaro, S
Structural and conformational study of β-blockers/β-cyclodextrin complexes 1-gen-2001 Ficarra, R; Raneri, D; Calabrò, M. L.; Tommasini, S; Alcaro, S; Ortuso, F; Ficarra, P
Conformational search of antisense nucleotides 1-gen-2001 Alcaro, S; Tafi, A.; Wozniak, L. A.; GÁCS-BAITZ, E.; Botta, M.; Ortuso, F
Screening virtuale di inibitori selettivi dell’SCF 1-gen-2002 Gontrani, L; Grieco, M; Incani, O; Ortuso, F; Rotiroti, D; Venuta, S; Alcaro, S
Rational drug design of Azinomycin analogs 1-gen-2002 Alcaro, S; Ortuso, F.; Coleman, R. S.
Arilpirrolidine ad Attivita’ Antinocicettiva: Preparazione e Profilo Farmacologico 1-gen-2002 Collina, S.; Azzolina, O.; Brusotti, G.; Rossi, D.; Barbieri, A.; Lanza, E.; Alcaro, S; Ghislandi, V.
Molecular modeling of paraquat and MPP+ recognition with acetylcholinesterse: implication in neurotoxicity 1-gen-2002 Alcaro, S; Ortuso, F; Battaglia, D; Vecchio, I; Iannone, M; Rotiroti, D
Molecular Modeling of Paraquat and MPP+ recognition with Acetylcholinesterase: implication in neurotoxicity 1-gen-2002 Alcaro, S; Ortuso, F.; Battaglia, D.; Vecchio, I.; Iannone, M.; Rotiroti, D.
Force field parameterization of selenium based nucleotides 1-gen-2002 Alcaro, S; Battaglia, D; Tafi, A; Botta, M; Ortuso, F
Enantioselective Semi-preparative HPLC of Two 2-Arylpropionic Acids on Glycopeptides Containing Chiral Stationary Phases 1-gen-2002 Alcaro, S; Dacquarica, I.; Gasparrini, F.; Misiti, D.; Pierini, M.; Villani, C.
Inhibition of Amine Oxidases Activity by 1-Acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole Derivatives 1-gen-2002 Manna, F.; Chimenti, F.; Bolasco, A.; Secci, D.; Bizzarri, B.; Befani, L.; Turini, P.; Mondovi`, B.; Alcaro, S; Tafi, A.
Modeling and biological evaluation of 3,3V-(1,2-ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 1-gen-2002 Ottana, R; Mazzon, E; Dugo, L; Monforte, F; Maccari, R; Sautebin, L; DE LUCA, G; Vigorita, M. G.; Ortuso, F; Caputi, A. P.; Cuzzocrea, S; Alcaro, S
Preparation, characterization,molecular modeling and in vitro activity of paclitaxel cyclodextrin complexes 1-gen-2002 Ventura, C. A.; Battaglia, D; Ortuso, F; Cattel, L; Puglisi, G; Alcaro, S; Fresta, M; Paolino, D
Molecular modeling and enzymatic studies of the interaction of a choline analogue and acetylcholinesterase 1-gen-2002 Scipione, L; Ortuso, F; Posca, S; Rispoli, V; Rotiroti, D; Alcaro, S
DNA Cross-Linking by Azinomycin B: Monte Carlo Simulations in the Evaluation of Sequence Selectivity 1-gen-2002 Ortuso, F; Coleman, R. S.; Alcaro, S
Drug design of selective monoaminoxidase inhibitors: synthesis, molecular modelling and enzymatic tests 1-gen-2003 Chimenti, F; Secci, D; Bolasco, A; Manna, F; Granese, A; Chimenti, P; Ortuso, F; Gallelli, A; Alcaro, S
Mostrati risultati da 41 a 60 di 478
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile